L&K Biomed, ExcelFix-XTP Surgery in the US, Australia, and Hong Kong

Spine implant specialist L&K Biomed announced on the 22nd that it has successfully completed the first surgeries using the height-adjustable cage ‘ExcelFix-XTP’ in the United States, Australia, and Hong Kong.

In the United States, the surgery was performed by Dr. Fredrick Jeon, a renowned expert at Beaumont Hospital in Detroit. In Australia, the procedure was conducted by Dr. John Choi of Peninsula Private Hospital, who has previous experience performing the surgery at Seoul National University Hospital last year. In Hong Kong, the surgery took place at Gleneagles Hospital under the direction of Dr. Philip Cheng, who has extensive experience in lateral lumbar fusion surgery.

Recently, Dr. Kangjun Yoon, CEO of Gangnam Bedro Hospital, also successfully completed the first surgery. Dr. Yoon is a pioneer in artificial disc surgery, having developed and patented an artificial disc tailored to the physique of Asians, and is also the author of the book I Was Also a Patient with a Herniated Disc.

Dr. Yoon stated, “The surgical outcomes showed good prognosis for the patients,” adding, “It seems that L&K Biomed has developed a competitive product that can expand its sales network not only domestically but also globally to Europe, Southeast Asia, and beyond.”

The ExcelFix-XTP is a patented height-adjustable cage that is the world’s first to apply a curved design, suitable for both lumbar lateral fusion and anterolateral fusion surgeries.

In traditional spine surgeries performed on the back, part of the bone often needs to be removed to access the disc. However, the new surgical technique allows the procedure to be done through the abdomen or side, eliminating the need to remove bone. This enables surgery without damaging organs or muscles, reducing operation time as well as the risks of excessive bleeding and infection during surgery. It also aids in faster patient recovery post-surgery, making it a globally acclaimed technique.

A company representative said, “Medical devices often face reluctance in overseas markets where medical lawsuits are frequent, especially regarding new products with risks, but we have successfully completed the first surgeries,” adding, “This has become a meaningful opportunity to showcase the product’s capabilities worldwide.”

This content was produced with the assistance of AI translation services.